Common Medications for Irritable Bowel Syndrome Under the Microscope

SadaNews - In the largest study of its kind, researchers have raised questions about the long-term safety of some medications used to treat irritable bowel syndrome (IBS). According to a report on the "ScienceDaily" website, some of these treatments have been associated with a slight but notable increase in the risk of death with prolonged use.

The study relied on data from over 650,000 patients in the United States, who were followed for about 20 years, giving the results significant statistical weight compared to shorter studies.

The findings showed that the use of antidepressants, which are sometimes prescribed to relieve IBS symptoms, was associated with a 35% increase in the risk of death. Additionally, some antidiarrheal medications, such as "Loperamide" and "Diphenoxylate," were linked to an almost doubling of risk compared to non-users.

Despite these figures, researchers emphasize that the study does not prove that the medications are the direct cause of death, as patients using them may be more susceptible to other health issues, such as heart disease, falls, or strokes.

The results also indicated that some other treatments, including approved medications for IBS and antispasmodics, were not associated with a similar increase in risks.

Low Individual Risks

Researchers stress that the additional risk at the individual level remains low, despite its statistical significance at the level of large groups. This comes in the context that IBS patients often use these medications for long periods, making it essential to understand their extended effects.

The study calls for a more individualized approach to treatment, taking into account the condition of each patient rather than relying on a single type of medication for prolonged periods. It also emphasizes the need for further studies to identify the groups most susceptible to these risks and to improve future treatment guidelines. These results highlight the importance of balancing benefits and risks in long-term treatment, with the necessity of consulting a physician to determine the most appropriate option for each case.